# US 2025/0367648 A1 · Enzyme-decorated nanocatalysts

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0367648 A1
- Document ID: US20250367648A1
- Status: Published application
- Kind: A1
- Application number: 19/222,494
- Filed: 2025-05-29
- Published: 2025-12-04
- Earliest claimed: 2024-05-29
- Assignees: Cassiopea S.P.A.
- Applicants: Cassiopea LLC
- Inventors: Keith LADEROUTE
- Web page: https://patentgrep.com/patent/US20250367648A1

## CPC

- B01J 31/003: {containing enzymes}
- C12P 21/02: having a known sequence of two or more amino acids, e.g. glutathione
- B01J 35/40: characterised by dimensions, e.g. grain size (in a colloidal state B01J35/23; crystallite size B01J35/77)
- C07K 14/00: Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C12N 1/12: Unicellular algae; Culture media therefor (as new plants A01H13/00)
- C12N 1/20: Bacteria; Culture media therefor
- C12N 9/88: Lyases (4.)
- C12P 3/00: Preparation of elements or inorganic compounds except carbon dioxide {(recovery of carbon dioxides as by-products C12F3/02)}
- C12Y 401/01039: Ribulose-bisphosphate carboxylase (4.1.1.39)
- C12Y 402/01001: Carbonate dehydratase (4.2.1.1), i.e. carbonic anhydrase
- C07K 2319/00: Fusion polypeptide
- C12R 2001/89: Algae {; Processes using algae}
- B01J: CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Y: ENZYMES
- C12R: INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS

## Abstract

Provided herein are vesicular nanocatalysts decorated on their surface with enzymes, such as for industrial use. More particularly, the nanocatalysts include outer membrane vesicles (OMVs) presenting on their surface carbonic anhydrase or a functional fragment or derivative thereof. Uses, methods of manufacture, and compositions of the nanocatalysts are also disclosed herein.

## Claims

### Claim 1

An engineered outer membrane vesicle (OMV) comprising a heterologous enzyme presented on the outer surface of the engineered OMV.

### Claim 2 (depends on 1)

The engineered OMV of claim 1, wherein the engineered OMV is obtained from a photosynthetic microorganism.

### Claim 3 (depends on 2)

The engineered OMV of claim 2, wherein the photosynthetic microorganism is an engineered photosynthetic organism.

### Claim 4 (depends on 2)

The engineered OMV of claim 2, wherein the photosynthetic microorganism is a gram-negative bacterium or eukaryotic microalgae.

### Claim 5 (depends on 4)

The engineered OMV of claim 4, wherein the gram-negative bacterium is a cyanobacterium selected from Synechocystis sp., Synechococcus sp., Microcystis aeruginosa, Leptolyngbya boryana, Cyanobium gracile, Phormidium persicinum, and Gloeocapsa sp.

### Claim 6 (depends on 1)

The engineered OMV of claim 1, wherein the heterologous enzyme is operably linked to a transmembrane protein embedded in the membrane of the engineered OMV to form a fusion protein.

### Claim 7 (depends on 6)

The engineered OMV of claim 6, wherein the transmembrane protein is derived from an:
autotransporter protein (ATP) selected from antigen 43 (Ag43), hemoglobin-binding protease (Hbp), pertactin, extracellular serine protease plasmid-encoded (EspP), IgA1 protease, esterase autotransporter (EstA), adhesion and penetration protein (Hap), adhesin involved in diffuse adherence (AIDA-I), plasmid-encoded toxin (Pet), protease involved in intestinal colonization (Pic), temperature-sensitive hemagglutinin (Tsh), shigella extracellular protein (SepA), and vacuolating cytotoxin A (VacA); or
OMP selected from Synechococcus outer membrane protein A (SomA), MipA, and ice nucleation proteins (INPs).

### Claim 8 (depends on 7)

The engineered OMV of claim 7, wherein the transmembrane protein comprises the amino acid sequence of any one of SEQ ID NOs: 8-12.

### Claim 9 (depends on 6)

The engineered OMV of claim 6, wherein the fusion protein further comprises a linker connecting the heterologous enzyme to the transmembrane protein.

### Claim 10 (depends on 1)

The engineered OMV of claim 1, wherein the engineered OMV comprises at least about 10 heterologous enzyme molecules presented on its outer surface.

### Claim 11 (depends on 1)

The engineered OMV of claim 1, wherein the heterologous enzyme comprises a carbonic anhydrase (CA) polypeptide or functional fragment thereof.

### Claim 12 (depends on 11)

The engineered OMV of claim 11, wherein the CA polypeptide is derived from a thermostable CA from Thermosulfurimonas dismutans or comprises the amino acid sequence of SEQ ID NO: 7.

### Claim 13

An engineered host cell capable of producing an OMV comprising a heterologous enzyme presented on the outer surface of the OMV, wherein the engineered host cell is a photosynthetic microorganism comprising heterologous nucleic acid encoding a fusion protein comprising the heterologous enzyme operably linked to a transmembrane protein, and wherein the fusion protein is capable of being inserted into the outer membrane of the engineered host cell such that the heterologous enzyme is presented on the outer surface of the engineered host cell.

### Claim 14 (depends on 13)

The engineered host cell of claim 13, wherein the transmembrane protein is derived from:
an autotransporter protein (ATP) selected from antigen 43 (Ag43), hemoglobin-binding protease (Hbp), pertactin, extracellular serine protease plasmid-encoded (EspP), IgA1 protease, esterase autotransporter (EstA), adhesion and penetration protein (Hap), adhesin involved in diffuse adherence (AIDA-I), plasmid-encoded toxin (Pet), protease involved in intestinal colonization (Pic), temperature-sensitive hemagglutinin (Tsh), shigella extracellular protein (SepA), and vacuolating cytotoxin A (VacA): or
an outer membrane protein (OMP), wherein the transmembrane protein derived from an OMP selected from Synechococcus outer membrane protein A (SomA), MipA, and ice nucleation proteins (INPs)

### Claim 15 (depends on 14)

The engineered host cell of claim 14, wherein the transmembrane protein comprises the amino acid sequence selected from SEQ ID NOs: 8-12.

### Claim 16 (depends on 13)

The engineered host cell of claim 13, wherein the fusion protein further comprises:
a linker connecting the heterologous enzyme to the transmembrane protein; and
a signal peptide capable of targeting the fusion protein to the inner membrane of the engineered host cell.

### Claim 17 (depends on 13)

The engineered host cell of claim 13, wherein the engineered host cell is a:
cyanobacterium selected from Synechocystis sp., Synechococcus sp., Microcystis aeruginosa, Leptolyngbya boryana, Cyanobium gracile, Phormidium persicinum, and Gloeocapsa sp: or
eukaryotic microalgae.

### Claim 18 (depends on 13)

The engineered host cell of claim 13, wherein the heterologous enzyme comprises a CA polypeptide or functional fragment thereof.

### Claim 19 (depends on 13)

The engineered host cell of claim 13, wherein the heterologous nucleic acid is present extrachromosomally and is integrated into the chromosome of the engineered host cell.

### Claim 20 (depends on 13)

A method of producing an engineered OMV comprising:
(a) culturing the engineered host cell according to claim 13 under conditions suitable for expression of the fusion protein; and
(b) obtaining an OMV produced by the engineered host cell,
thereby producing the engineered OMV.

### Claim 21 (depends on 20)

The method of claim 20, wherein the engineered host cell is cultured in the presence of CO2 and light, and wherein the method further comprises filtering the engineered OMV.

### Claim 22 (depends on 1)

A nanocatalyst composition comprising the engineered OMV of claim 1.

### Claim 23 (depends on 22)

The nanocatalyst composition of claim 22, comprising the engineered OMV at a concentration greater than about 100 mg/L or 10 g.

### Claim 24 (depends on 22)

The nanocatalyst of claim 22, wherein the composition is not a therapeutic composition.

### Claim 25 (depends on 11)

A method of reducing CO2 comprising interacting the engineered OMV according to claim 11 with CO2 under a condition suitable for the CA polypeptide or functional fragment thereof to convert CO2 to a catalysis product.

### Claim 26 (depends on 25)

The method of claim 25, wherein the catalysis product is a metal carbonate.

### Claim 27 (depends on 26)

The method of claim 26, wherein the engineered OMV is interacted with CO2 in the presence of H2O and a metal ion under alkaline conditions suitable for (i) the conversion of CO2 to CO32− by the CA polypeptide or functional fragment thereof, and (ii) association of CO32− with the metal ion to form the metal carbonate.

### Claim 28 (depends on 27)

The method of claim 27, wherein the metal ion is Ca2+, Mg2+, Fe2+, Zn2+, Cu2+, Mn2+, or Li+.

### Claim 29 (depends on 25)

The method of claim 25, wherein the engineered OMV is interacted with CO2 in air, water, or waste.

### Claim 30

A system for the production of an engineered outer membrane vesicle (OMV) and for catalyzing the conversion of CO2 and H2O to HCO3− and H+, the system comprising:
(a) a first reactor configured to receive a microorganism capable of producing the engineered OMV:
(b) a receptacle configured to receive the engineered OMV produced in the first reactor, wherein the receptable is capable of being in conditions suitable for carrying out the conversion of CO2 and H2O to HCO3− and H+; and
(c) a filtration interface connecting the first reactor to the receptable, wherein the engineered OMV produced in the first reactor is capable of passing through the filtration interface into the receptacle.
